刘悦;赵亚男;赵哲;刘宏潇;

• 1:中国中医科学院广安门医院

摘要(Abstract)：

<正>强直性脊柱炎(ankylosing spondylitis, AS) 是一种以中轴关节和肌腱韧带骨附着点的慢性炎症为主的难治性免疫相关性疾病，为临床常见的脊柱关节病类型。主要侵犯脊柱及骶髂关节，并可伴有关节外表现，随病情进展，患者可出现脊柱活动受限、强直、髋关节破坏等，严重者可致残，严重影响患者生活质量。我国的患病率初步调查约为0.3%,常累及20～40岁的中青年男性^([1])。

关键词(KeyWords)： 固有免疫;适应性免疫;强直性脊柱炎

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目(81873292)

作者(Authors): 刘悦;赵亚男;赵哲;刘宏潇;

参考文献(References)：

• [1] 中华医学会风湿病学分会.强直性脊柱炎诊断及治疗指南[J].中华风湿病学杂志，2010,14(8):557-559. [2] Navid D,Mahdi M,Saeed A,et al.HLA-B*27 subtypes and their implications in the pathogenesis of ankylosing spondylitis[J].Gene,2018,670:15-21. [3] Zhang L,Zhang Y J,Chen J,et al.The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis:A systematic review[J].Microb Pathog,2018,117:49-54. [4] Tapia-Serrano R,Jimenez-Balderas F J,Murrieta S,et al.Testicular function in active ankylosing spondylitis.Therapeutic response to human chorionic gonadotrophin[J].J Rheumatol,1991,18(6):841-848. [5] Costello M E,Ciccia F,Willner D,et al.Intestinal dysbiosis in ankylosing spondylitis[J].arthritis rheumatol,2014,67(3):686-691. [6] Francois J R.Immunohistological examination of open s-acroiliac biopsies of patients with ankylosing spondylitis:detection of tumour necrosis factor Alpha in two patients with early disease and transforming growth factor Beta in three more advanced cases[J].Ann Rheum Dis,2006,65(6):713-720. [7] 孙素和，王鹏，苏春燕.强直性脊柱炎患者骨髓间充质干细胞调控巨噬细胞的功能异常[J].中国组织工程研究，2016,20(1):13-19. [8] Im C H,Kang E H,Ki J Y,et al.Receptor activator of nuclear factor kappa B ligand-mediated osteoclastogenesis is elevated in ankylosing spondylitis[J].Clin Exp Rheumatol,2009,27(4):620-625. [9] Kylmaoja E,Nakamura M,Tuukkanen J.Osteoclasts and Remodeling Based Bone Formation[J].Curr Stem Cell Res T,2016,11(8):626-633. [10] Lin S,Qiu M,Chen J.IL-4 Modulates Macrophage Polarization in Ankylosing Spondylitis[J].Cell Physiol Biochem,2015,35(6):2213-2222. [11] Ranganathan V,Ciccia F,Zeng F,et al.Macrophage Migration Inhibitory Factor induces inflammation and predicts spinal progression in Ankylosing Spondylitis[J].Arthritis Rheumatol,2017,69(9):1796-1806. [12] Ivana Stojanovic,Tamara Cvjeticanin,Lazaroski S,et al.Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells[J].Immunology,2009,126(1):74-83. [13] Park Min-Chan,Kwon Oh Chan,Lee Sang-Won,et al.MiR-451 suppresses inflammatory responses in ankylosing spondylitis by targeting macrophage migration inhibitory factor[J].Clin Exp Rheumatol,2020,38(2):275-281. [14] P?ll?nen Raimo,Sillat Tarvo,Pajarinen Jukka,et al.Microbial antigens mediate HLA-B27 diseases via TLRs[J].J autoimmun,2009,32(3-4). [15] Yang Z X,Liang Y,Zhu Y,et al.Increased expression of Toll-like receptor 4 in peripheral blood leucocytes and serum levels of some cytokines in patients with ankylosing spondylitis[J].Clin Exp Immunol,2010,149(1):48-55. [16] Jun Zhang,Rongming Xu,Lei Wu,et al.Expression and Function of Tolllike Receptors in Peripheral Blood Mononuclear Cells in Patients With Ankylosing Spondylitis[J].Mol Med Rep,2019,20(4):3565-3572. [17] Ricklin D,Lambris J D.Complement-targeted therapeutics[J].Adv Exp Med Biol,2013,735(11):197. [18] Yang C,Ding P,Wang Q,et al.Inhibition of Complement Retards Ankylosing Spondylitis Progression[J].Sci Rep,2016,6:34643. [19] Fuller K.A role for TGFbeta(1) in osteoclast differentiation and survival[J].J Cell Sci,2000,113(Part 13):2445-2453. [20] 陈兵华，王峰，邬丽娜.强直性脊柱炎患者血清补体B因子及免疫球蛋白测定的临床意义[J].医学研究杂志，2015,44(10):135-137. [21] Spits H,Cupedo T.Innate Lymphoid Cells:Emerging Insights in Development,Lineage Relationships,and Function[J].Annu Rev Immunol,2012,30(1):647-675. [22] Yazdani Reza,Mehri Sharifi,Aylar Saba Shirvan,et al.Characteristics of innate lymphoid cells (ILCs) and their role in immunological disorders (an update)[J].Cell Immunol,2015,298(1-2):66-76. [23] Gladiator A,Wangler N,Trautwein-Weidner K,et al.Cutting Edge:IL-17-Secreting Innate Lymphoid Cells Are Essential for Host Defense against Fungal Infection[J].J Immunol,2013,190(2):521-525. [24] Guo C J,Zhang W,Gershwin M E.Long noncoding RNA lncKdm2b:A critical player in the maintenance of group 3 innate lymphoid cells[J].Cell Mol Immunol,2018,15(1):5-7. [25] Ciccia F,Guggino G,Rizzo A,et al.Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut,in the peripheral blood,synovial fluid and bone marrow of patients with ankylosing spondylitis[J].Ann rheum dis,2015,74(9):1739-1747. [26] Al-Mossawi M H,Chen L,Fang H,et al.Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis[J].Nat Commun,2017,8(1):1510. [27] Jacques P,Elewaut D,Mielants H.Interactions between gut inflammation and arthritis/spondylitis[J].Curr Opin Rheumatol,2010,22(4):368-374. [28] Claire Pearson,Emily E Thornton,Brent McKenzie,et al.ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation[J].Elife,2016,5:e10066. [29] Maksymowych W P.Disease modification in ankylosing spondylitis[J].Nat Rev Rheumatol,2010,6(2):75-81. [30] Honda K,Littman D R.The microbiota in adaptive immune homeostasis and disease[J].Nature,2016,535(7610):75-84. [31] Mandy J McGeachy,Yi Chen,Cristina M Tato,et al.Interleukin 23 receptor is essential for terminal differentiation of effector T helper type 17 cells in vivo[J].Nat Immunol,2009,10(3):314. [32] Mei Y,Pan F,Gao J,et al.Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis[J].Clin Rheumatol,2011,30(2):269-273. [33] Farhad B,Milad H,Hamed M,et al.The role of gut microbiota and IL-23/IL-17 pathway in ankylosing spondylitis immunopathogenesis:New insights and updates[J].Immunol Lett,2018,196:52-62. [34] Ennio L,Massimo P F.Secukinumab for ankylosing spondylitis and psoriatic arthritis[J].Ther Clin Risk Manag,2016,12:1587-1592. [35] Hammitzsch A,Chen L,De Wit J,et al.Inhibiting ex-vivo Th17 responses in Ankylosing Spondylitis by targeting Janus kinases[J].Sci Rep,2018,8(1):15645. [36] Lai N L,Zhang S X,Wang J,et al.The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis:A Meta-Analysis[J].J Immunol Res,2019,2019(12):1-11. [37] Wang M,Liu C,Bond A,et al.Dysfunction of regulatory T cells in patients with ankylosing spondylitis is associated with a loss of Tim-3[J].Int Immunopharmacol,2018,59:53-60. [38] Ciccia F,Accardo-Palumbo A,Giardina A R,et al.Expansion of intestinal CD4+ CD25(high) Treg cells in patients with ankylosing spondylitis:a putativfe role for interleukin-10 in preventing intestinal Th17 response[J].Arthritis Rheumatol,2010,62(12):3625-3634. [39] Crotty S.Follicular helper CD4 T cells (TFH)[J].Annu rev immunol,2011,29(1):621. [40] Zotos D,Coquet J M,Zhang Y,et al.IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism[J].J Exp Med,2010,207(2):365-378. [41] Wu S,Yang T,Pan F,et al.Increased frequency of circulating follicular helper T cells in patients with ankylosing spondylitis[J].Mod Rheumatol,2015,25(1):110-115. [42] Havenar-Daughton C,Lindqvist M,Heit A,et al.CXCL13 is a plasma biomarker of germinal center activity[J].Proc Natl Acad Sci USA,2016,113(10):2702-2707. [43] 姚林虎，孟景红，李雪.滤泡辅助性T细胞及白细胞介素-21趋化因子CXC配体13在强直性脊柱炎患者中的作用[J].中华风湿病学杂志，2014,18(8):552-554. [44] Qu L,Jie-Ruo G U,Tian-Wang L I,et al.Value of the peripheral blood B-cells subsets in patients with ankylosing spondylitis[J].Chin Med J(Engl),2009,122(15):1784-1789. [45] 吴洪坤，周琳，张玲珍.强直性脊柱炎患者外周血中B淋巴细胞亚群、B细胞活化因子及其受体的表达研究[J].检验医学，2011,26(12):818-822. [46] Chen M,Zhang L,Ren Y,et al.Defective Function of CD24+ CD38+ Regulatory B Cells in Ankylosing Spondylitis[J].Dna Cell Bio,2016,35(2):88-95.

文章评论(Comment)：